IPO
-
-
-
-
-
-
-
Fate Therapeutics Appoints Yuan Xu to its Board of Directors
-
-
-
-
-
-
-
NetworkNewsBreaks – Akero Therapeutics, Inc. (NASDAQ: AKRO) Closes $105.8 Million IPO
-
-
-
-
124,450 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

